Douglas Kerr - Jan 15, 2024 Form 4 Insider Report for Generation Bio Co. (GBIO)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Benjamin Waters, Attorney-in-Fact
Stock symbol
GBIO
Transactions as of
Jan 15, 2024
Transactions value $
-$9,353
Form type
4
Date filed
1/17/2024, 05:00 PM
Previous filing
Oct 17, 2023
Next filing
Jan 31, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GBIO Common Stock Options Exercise +7.44K +1.99% 380K Jan 15, 2024 Direct F1, F2
transaction GBIO Common Stock Tax liability -$4.92K -2.58K -0.68% $1.91 378K Jan 15, 2024 Direct
transaction GBIO Common Stock Options Exercise +6.69K +1.77% 384K Jan 15, 2024 Direct F1
transaction GBIO Common Stock Tax liability -$4.43K -2.32K -0.6% $1.91 382K Jan 15, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GBIO Restricted Stock Units Options Exercise $0 -7.44K -50% $0.00 7.44K Jan 15, 2024 Common Stock 7.44K Direct F1, F3
transaction GBIO Restricted Stock Units Options Exercise $0 -6.69K -25% $0.00 20.1K Jan 15, 2024 Common Stock 6.69K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Douglas Kerr is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive one share of the company's common stock.
F2 Includes 2,445 shares acquired under the company's employee stock purchase plan since October 17, 2023.
F3 On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.
F4 On January 20, 2023, the reporting person was granted 26,775 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter.